dsccfae
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01382095)
Timeline
Indications
Studied for
Mechanism of action
- Heat-stable enterotoxin receptorImmunity, active
GUCY2C immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dsccfae
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01922856 | Phase 2 | Sep 19, 2013 | Johns Hopkins University, United States Army |
| NCT01644565 | Phase 1 | Aug 1, 2012 | United States Army, United States Navy |
| NCT01382095 | Phase 1 | Jul 1, 2011 | United States Army, United States Navy |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| United States Army | Government | 3 | 3 | 2 | 2011 |
| United States Navy | Government | 2 | 0 | 1 | 2011 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1